Trupanion (TRUP) Upgraded by Zacks Investment Research to Hold
According to Zacks, “Trupanion, Inc. operates as a direct-to-consumer monthly subscription service provider of a medical insurance plan for cats and dogs. It operates primarily in Canada, Puerto Rico, and the United States. The Company serves pet owners and veterinarians. Trupanion, Inc. is headquartered in Seattle, Washington. “
TRUP has been the topic of a number of other reports. ValuEngine upgraded Trupanion from a “hold” rating to a “buy” rating in a research note on Friday, February 15th. BidaskClub upgraded Trupanion from a “hold” rating to a “buy” rating in a research note on Saturday, February 9th. Guggenheim began coverage on Trupanion in a research note on Thursday. They issued a “buy” rating and a $35.00 price target on the stock. Finally, Northland Securities began coverage on Trupanion in a report on Tuesday, May 14th. They issued a “buy” rating and a $40.00 target price on the stock. One equities research analyst has rated the stock with a hold rating and twelve have issued a buy rating to the company’s stock. The stock presently has an average rating of “Buy” and a consensus price target of $43.90.
Trupanion (NASDAQ:TRUP) last released its quarterly earnings results on Thursday, May 2nd. The financial services provider reported ($0.04) earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of ($0.01) by ($0.03). The firm had revenue of $86.98 million during the quarter, compared to analysts’ expectations of $85.87 million. Trupanion had a negative return on equity of 0.59% and a negative net margin of 0.23%. The business’s quarterly revenue was up 24.7% on a year-over-year basis. During the same quarter last year, the business earned ($0.05) earnings per share. As a group, analysts expect that Trupanion will post -0.03 earnings per share for the current year.
In other Trupanion news, insider Asher Bearman sold 12,500 shares of the firm’s stock in a transaction dated Tuesday, April 2nd. The stock was sold at an average price of $35.00, for a total transaction of $437,500.00. Following the sale, the insider now directly owns 14,891 shares of the company’s stock, valued at $521,185. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, CEO Darryl Rawlings sold 4,000 shares of the firm’s stock in a transaction dated Monday, February 25th. The shares were sold at an average price of $29.70, for a total value of $118,800.00. Following the transaction, the chief executive officer now owns 1,547,421 shares of the company’s stock, valued at approximately $45,958,403.70. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 104,003 shares of company stock worth $3,284,293. 13.61% of the stock is owned by insiders.
Institutional investors have recently modified their holdings of the company. Alpha Omega Wealth Management LLC grew its position in shares of Trupanion by 110.8% during the first quarter. Alpha Omega Wealth Management LLC now owns 843 shares of the financial services provider’s stock valued at $28,000 after purchasing an additional 443 shares in the last quarter. Manchester Capital Management LLC boosted its holdings in shares of Trupanion by 100.9% in the first quarter. Manchester Capital Management LLC now owns 1,710 shares of the financial services provider’s stock valued at $56,000 after acquiring an additional 859 shares in the last quarter. Catalyst Capital Advisors LLC purchased a new stake in shares of Trupanion in the fourth quarter valued at about $59,000. Citigroup Inc. boosted its holdings in shares of Trupanion by 12,818.2% in the fourth quarter. Citigroup Inc. now owns 2,842 shares of the financial services provider’s stock valued at $72,000 after acquiring an additional 2,820 shares in the last quarter. Finally, Great West Life Assurance Co. Can boosted its holdings in shares of Trupanion by 105.1% in the fourth quarter. Great West Life Assurance Co. Can now owns 3,691 shares of the financial services provider’s stock valued at $91,000 after acquiring an additional 1,891 shares in the last quarter. Hedge funds and other institutional investors own 95.66% of the company’s stock.
Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on monthly subscription basis in the United States, Canada, and Puerto Rico. The company operates through Subscription Business and Other Business segments. It serves pet owners and veterinarians through third-party referrals and online member acquisition channels.
Featured Story: What is the formula for the cash asset ratio?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.